Literature DB >> 36128487

Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO.

Sandra M Herrmann1.   

Abstract

Entities:  

Keywords:  acute kidney injury; acute kidney injury and ICU nephrology; debates; immune checkpoint inhibitor; rechallenge

Mesh：

Substances：

Year:  2021        PMID： 36128487      PMCID： PMC9438431          DOI： 10.34067/KID.0003962021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  12 in total

1.  Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.

Authors:  M Espi; C Teuma; E Novel-Catin; D Maillet; P J Souquet; S Dalle; L Koppe; D Fouque
Journal:  Eur J Cancer       Date:  2021-02-16       Impact factor: 9.162

2.  Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.

Authors:  Sandhya Manohar; Ranine Ghamrawi; Madhuri Chengappa; Busra N Bacik Goksu; Lisa Kottschade; Heidi Finnes; Roxana Dronca; Konstantinos Leventakos; Joerg Herrmann; Sandra M Herrmann
Journal:  Kidney360       Date:  2020-01-07

3.  Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Ian A Strohbehn; Meghan Lee; Donald F Chute; Halla Bates; Gabriel E Molina; Leyre Zubiri; Shruti Gupta; Shveta Motwani; David E Leaf; Ryan J Sullivan; Osama Rahma; Kimberly G Blumenthal; Alexandra-Chloe Villani; Kerry L Reynolds; Meghan E Sise
Journal:  Kidney Int Rep       Date:  2020-07-21

4.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

Review 5.  Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review.

Authors:  A Garant; C Guilbault; T Ekmekjian; Z Greenwald; P Murgoi; T Vuong
Journal:  Crit Rev Oncol Hematol       Date:  2017-10-27       Impact factor: 6.312

6.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

7.  Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events.

Authors:  Busra Isik; Mariam P Alexander; Sandhya Manohar; Lisa Vaughan; Lisa Kottschade; Svetomir Markovic; John Lieske; Aleksandra Kukla; Nelson Leung; Sandra M Herrmann
Journal:  Kidney Int Rep       Date:  2021-02-02

8.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121

9.  Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.

Authors:  Charles Dolladille; Stéphane Ederhy; Marion Sassier; Jennifer Cautela; Franck Thuny; Ariel A Cohen; Sophie Fedrizzi; Basile Chrétien; Angélique Da-Silva; Anne-Flore Plane; Damien Legallois; Paul U Milliez; Véronique Lelong-Boulouard; Joachim Alexandre
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.